9 research outputs found

    A Between-sex Comparison of the Validity of Body Fat Percentage Estimates From Four Bioelectrical Impedance Analyzers

    Get PDF
    Bioelectrical impedance analysis (BIA) devices administer electrical currents through surface electrodes in contact with the hands and/or feet. The measured reactance and resistance of various bodily tissues to these currents are then used to estimate body fat percentage (BFP) and other body composition values of interest based on algorithms derived from validation data. Owing to different patterns of fat distribution between sexes, it is unclear whether the configuration of electrodes (i.e., hand-to-hand, foot-to-foot, or hand-to-foot) may affect the validity of these devices in males versus females. PURPOSE: The purpose of this study was to determine the validity of BFP values across four BIA devices – one consumer-grade foot-to-foot device (RENPHO Smart Bathroom Scale), one consumer-grade hand-to-hand device (Omron HBF-306), one consumer-grade octapolar device (InBody H20N), and one research-grade octapolar device (Seca mBCA 515/514) – against a criterion four-compartment model (4C), and to compare these values between males and females. METHODS: Seventy-four healthy participants (35 males and 39 females) were included in this analysis. Participants abstained from all food, fluid, caffeine, and alcohol for at least 8 hours prior to each visit. Total error (TE) was calculated as the root mean square error between the estimate of each BIA device and that of the 4C model. Standard error of the estimate (SEE) was defined as the residual standard error value from ordinary least squares regression. Constant error (CE) was calculated as the average difference between the estimate of each BIA device and that of the 4C model. RESULTS: Participants had a mean ±SD age of 27.2 ±7.3 years, height of 168.1 ±8.9 cm, weight of 72.2 ±16.7 kg, and 4C BFP of 24.9 ±9.2%. In the entire sample, ranges for validity metrics of interest were as follows: TE: 3.2% (Seca) to 7.2% (RENPHO); SEE: 3.3% (Seca) to 5.7% (RENPHO); CE: -0.02 ±3.4% (InBody) to -3.46 ±4.1% (Omron). Across all devices, both TE and SEE were lower in females, with the largest between-sex differences observed for the InBody and RENPHO. Both octapolar devices (InBody and Seca) exhibited low group-level error in males and females (all CE within ±0.32%). Meanwhile, the RENPHO and Omron devices generally underestimated BFP with a greater degree of underestimation in females (CE of -2.6% and -3.7%, respectively) than males (CE of -0.1% and -3.2%, respectively), particularly for the RENPHO. CONCLUSION: Among the four BIA devices investigated, octapolar devices tended to have higher validity overall. All devices demonstrated lower TE and SEE in females, with the greatest between-sex differences observed in the InBody and RENPHO models. Users should be aware that commercially available hand-to-hand or foot-to-foot BIA devices such as the Omron and RENPHO models used in this study may systematically underestimate BFP compared to a criterion 4C model. In contrast, hand-to-foot octapolar analyzers exhibit strong group-level validity in both sexes

    Day-to-Day Precision Error and Least Significant Change for Two Commonly Used Bioelectrical Impedance Analysis Devices

    Get PDF
    Bioelectrical impedance analysis (BIA) devices administer electrical currents through surface electrodes to estimate overall body fluids from the measured resistance and reactance of bodily tissues. The proportion of fat versus fat-free mass can be further estimated by these devices using algorithms developed from reference data. BIA devices are commonly used in field as well as laboratory settings due to their convenience, ease of use, and relatively low cost. PURPOSE: The purpose of this study was to determine the day-to-day precision error (PE) and least significant change (LSC) of the percent body fat (PBF), fat mass (FM), and fat-free mass (FFM) estimated by two commonly used BIA devices, the InBody 770 and the Omron HBF-306. METHODS: Seventeen healthy participants (7 males, 10 females) were included in this analysis. Participants visited the laboratory on two separate occasions no more than 48 hours apart and abstained from all food, fluid, caffeine, and alcohol for at least 8 hours prior to each visit. Height and weight were measured using a Seca 769 stadiometer and digital scale. PE was calculated as , where SD is the within-subject standard deviation. LSC was calculated as 2.77 * PE to reflect a 95% confidence level. RESULTS: Participants had a mean ±SD age of 27.1 ±8.3 years, height of 171.6 ±8.5 cm, and weight of 68.0 ±10.6 kg. PE for the InBody was 1.0%, 0.7 kg, and 0.9 kg for PBF, FM, and FFM, respectively; PE for the Omron was 0.6%, 0.4 kg, and 0.6 kg for the same variables. The LSC values of each variable for the InBody were 2.8%, 1.9 kg, and 2.4 kg for PBF, FM, and FFM, respectively; the LSC values for these variables were 1.5%, 1.0 kg, and 1.6 kg for the Omron device. CONCLUSION: Individuals looking to use BIA as a method of detecting true changes in body composition over time should be aware that day-to-day measurement error between estimates were as as high as 1.0% for body fat, 0.7 kg for fat mass, and 0.9 kg for fat-free mass in the current study; therefore, changes within these parameters likely reflect error of measurement and not true physiological differences. Additionally, changes over time between estimates from an InBody 770 device should meet or exceed a difference of at least 2.8% body fat, 1.9 kg FM, or 2.4 kg FFM to increase confidence that the differences are a reflection of physiological changes rather than between-day measurement error; differences between readings from an Omron should meet or exceed 1.5% body fat, 1.0 kg FM, or 1.6 kg FFM for this purpose. The InBody 770 demonstrated higher precision error and thus may entail a higher least significant change to meaningfully detect true physiological changes between time points. However, the observed differences in these values between the InBody 770 and Omron HBF-306 may also indicate that the InBody 770 is more sensitive to small but real changes in bioelectrical impedance values between days. Longitudinal studies are needed to elucidate the comparative tracking validity of these commonly used BIA devices in healthy populations

    Evaluation of novel beverage formulations for hydration enhancement in humans

    Get PDF
    This study evaluated the influence of novel beverage formulations on bioimpedance- and urine-based hydration markers. Thirty young healthy adults (n=16 females, n=14 males; age: 23.2±3.7 years; BMI: 24.3±3.3 kg/m2 ) participated in a randomized, double-blind, placebo-controlled, crossover study. Participants completed three conditions with baseline bioimpedance, urine, and body mass assessments, followed by ingestion of one liter of a test beverage over a 30-minute period. The three beverages were: active hydration formulation in still (AFstill) or sparkling (AFspark) water and a still water control. The active formulations were identical in concentrations of alpha-cyclodextrin and complexing agents. Following beverage ingestion, bioimpedance assessments were performed every 15 minutes for two hours, followed by final urinary and body mass assessments. The primary bioimpedance outcomes were phase angle at 50 kHz, resistance of the extracellular compartment (R0), and resistance of the intracellular compartment (Ri). Data were analyzed using linear mixed effects models, Friedman tests, and Wilcoxon tests. Statistically significant changes in phase angle values were observed at 30 (p=0.004) and 45 minutes (p=0.024) following the initiation of beverage ingestion in the AFstill condition as compared to the reference model (i.e., control condition at baseline). Although differences between conditions were not statistically significant at later time points, the data were consistent with AFstill having greater elevations in phase angle throughout the monitoring period. At the 30-minute time point only, statistically significant differences in R0 for AFspark (p\u3c0.001) and in Ri for AFstill (p=0.008) were observed. When averaged across post-ingestion time points, there was a trend (p=0.08) for Ri differences between conditions. The net fluid balance was greater than zero, indicating retention of ingested fluid, for AFstill (p=0.02) and control (p=0.03), with a trend for AFspark (p=0.06). In conclusion, an active formulation containing alpha-cyclodextrin in still water demonstrated potential benefits for enhancing hydration markers in humans

    Day-to-Day Precision Error and Least Significant Change for Two Commonly Used Bioelectrical Impedance Analysis Devices

    Get PDF
    Bioelectrical impedance analysis (BIA) devices administer electrical currents through surface electrodes to estimate overall body fluids from the measured resistance and reactance of bodily tissues. The proportion of fat versus fat-free mass can be further estimated by these devices using algorithms developed from reference data. BIA devices are commonly used in field as well as laboratory settings due to their convenience, ease of use, and relatively low cost. PURPOSE: The purpose of this study was to determine the day-to-day precision error (PE) and least significant change (LSC) of the percent body fat (PBF), fat mass (FM), and fat-free mass (FFM) estimated by two commonly used BIA devices, the InBody 770 and the Omron HBF-306. METHODS: Seventeen healthy participants (7 males, 10 females) were included in this analysis. Participants visited the laboratory on two separate occasions no more than 48 hours apart and abstained from all food, fluid, caffeine, and alcohol for at least 8 hours prior to each visit. Height and weight were measured using a Seca 769 stadiometer and digital scale. PE was calculated as , where SD is the within-subject standard deviation. LSC was calculated as 2.77 * PE to reflect a 95% confidence level. RESULTS: Participants had a mean ±SD age of 27.1 ±8.3 years, height of 171.6 ±8.5 cm, and weight of 68.0 ±10.6 kg. PE for the InBody was 1.0%, 0.7 kg, and 0.9 kg for PBF, FM, and FFM, respectively; PE for the Omron was 0.6%, 0.4 kg, and 0.6 kg for the same variables. The LSC values of each variable for the InBody were 2.8%, 1.9 kg, and 2.4 kg for PBF, FM, and FFM, respectively; the LSC values for these variables were 1.5%, 1.0 kg, and 1.6 kg for the Omron device. CONCLUSION: Individuals looking to use BIA as a method of detecting true changes in body composition over time should be aware that day-to-day measurement error between estimates were as as high as 1.0% for body fat, 0.7 kg for fat mass, and 0.9 kg for fat-free mass in the current study; therefore, changes within these parameters likely reflect error of measurement and not true physiological differences. Additionally, changes over time between estimates from an InBody 770 device should meet or exceed a difference of at least 2.8% body fat, 1.9 kg FM, or 2.4 kg FFM to increase confidence that the differences are a reflection of physiological changes rather than between-day measurement error; differences between readings from an Omron should meet or exceed 1.5% body fat, 1.0 kg FM, or 1.6 kg FFM for this purpose. The InBody 770 demonstrated higher precision error and thus may entail a higher least significant change to meaningfully detect true physiological changes between time points. However, the observed differences in these values between the InBody 770 and Omron HBF-306 may also indicate that the InBody 770 is more sensitive to small but real changes in bioelectrical impedance values between days. Longitudinal studies are needed to elucidate the comparative tracking validity of these commonly used BIA devices in healthy populations

    Chronic Thermogenic Dietary Supplement Consumption: Effects on Body Composition, Anthropometrics, and Metabolism

    No full text
    Multi-ingredient thermogenic supplements can acutely increase resting energy expenditure (REE) and subjective energy. However, less is understood about the effects of chronic consumption on body composition, metabolism, and subjective variables such as mood, sleep quality, and eating behaviors. Fifty-two healthy, exercise-trained participants (50% female; mean ± SD age: 23.5 ± 3.0 years; body fat percentage: 27.3 ± 8.0%) were randomized 2:2:1 to take a whey protein supplement alone (PRO; n = 20), in combination with a thermogenic supplement (PRO + FB; n = 19), or no supplement at all (CON; n = 13) for four weeks. Body composition, anthropometric, metabolic, hemodynamic, and subjective outcomes were collected before and after the intervention. Greater changes in REE occurred in PRO + FB as compared to CON (111.2 kcal/d, 95% CI 2.4 to 219.9 kcal/d, p = 0.04), without significant differences between PRO and CON (42.7 kcal/d, 95% CI −65.0 to 150.3 kcal/d, p = 0.61) or between PRO + FB and PRO (68.5 kcal/d, 95% CI −28.3, 165.3, p = 0.21). No changes in hemodynamic outcomes (blood pressure and heart rate) were observed. In exercising adults, four weeks of supplementation with protein and a multi-ingredient thermogenic product maintained fasted REE as compared to no supplementation, for which a decrease in REE was observed, without differential effects on body composition, anthropometrics, or subjective variables

    The influence of caffeinated and non-caffeinated multi-ingredient pre-workout supplements on resistance exercise performance and subjective outcomes

    No full text
    Background There is substantial consumer and practitioner interest in an emerging supplement class known as multi-ingredient pre-workout supplements (MIPS), largely due to their prevalence in resistance training communities as well as research findings demonstrating the ergogenic impact of caffeine on muscular performance. However, limited research has examined the potential efficacy of non-caffeinated MIPS, despite their growing popularity among those who are caffeine-sensitive or who train later in the day. Methods Twenty-four resistance-trained college-aged males (n = 12) and females (n = 12) completed three visits in which they ingested either a caffeinated MIPS (C), an otherwise identical non-caffeinated MIPS (NC), or placebo in a double-blind, counterbalanced, crossover fashion. Squat isometric peak force (PFiso), rate of force development (RFD), and isokinetic performance were assessed. Upper and lower body maximal muscular strength and endurance were evaluated using the bench press and leg press, respectively. Visual analog scales for energy, focus, and fatigue were completed five times throughout the testing protocol. The effects of supplementation and biological sex on all variables were examined using linear mixed effects models. Results Significantly greater PFiso was observed in both C (b: 0.36 transformed units [0.09, 0.62]) and NC (b: 0.32 transformed units [95% CI: 0.05, 0.58]) conditions, relative to placebo. Early RFD (RFD50) may have been higher with supplementation, particularly in females, with no effects for late RFD (RFD200) or peak RFD. In addition, increases in subjective energy after supplement ingestion were noted for C, but not NC. No effects of supplementation on traditional resistance exercise performance or isokinetic squat performance were observed, other than a lower leg press one-repetition maximum for males in the NC condition. Conclusions These data indicate that acute ingestion of either a caffeinated or non-caffeinated pre-workout formulation improved maximal force production during an isometric squat test but did not provide additional benefit to leg press, bench press, or isokinetic squat performance over placebo, within the context of a laboratory environment. The consumption of a caffeinated, but not non-caffeinated, MIPS increased subjective ratings of energy over placebo when assessed as part of a testing battery

    No Effect of Breakfast Consumption Observed for Afternoon Resistance Training Performance in Habitual Breakfast Consumers and Nonconsumers: A Randomized Crossover Trial

    No full text
    Background Pre-exercise meal frequency is commonly believed to impact exercise performance, but little is known about its impact on resistance training. Objective This study investigated the impact of breakfast consumption on afternoon resistance training performance in habitual breakfast consumers and nonconsumers. Design A randomized, crossover study was conducted in Lubbock, TX between November 2021 and May 2022. Participants Thirty-nine resistance-trained male (n = 20) and female (n = 19) adults (mean ± SD age 23.0 ± 4.7 years) who habitually consumed (≥5 d/wk; n = 19) or did not consume (≥5 d/wk; n = 20) breakfast completed the study. Intervention After the establishment of 1-repetition maximums at the first visit, participants completed 2 additional visits, each of which included 4 sets of barbell back squat, bench press, and deadlift, using 80% of their 1-repetition maximum after either consuming breakfast and lunch or the same food at lunch only. Main outcome measures Repetitions, along with average and peak average concentric velocity and power, were measured for all repetitions throughout each exercise session. Visual analog scales were used to assess feelings of fatigue, energy, focus, hunger, desire to eat, and fullness throughout each exercise session. Statistical analyses performed Data were analyzed using linear mixed-effects models. Results No interactions or main effects involving condition or habitual breakfast consumption were observed for resistance training outcomes, although sex differences were noted. Male participants performed significantly fewer repetitions on sets 2, 3, and 4 (P \u3c .014) for total repetitions, on sets 2 and 4 for barbell back squat (P \u3c .023), and set 4 for deadlift (P = .006), with no observed differences between sexes for bench press repetitions. Male participants displayed reductions in average power across all sets and exercises except deadlift. Conclusions These data suggest that alterations in pre-exercise meal frequency may not influence afternoon resistance training performance provided similar total nutritional intake is consumed

    Effects of a ready-to-drink thermogenic beverage on resting energy expenditure, hemodynamic function, and subjective outcomes

    No full text
    Background Thermogenic supplements are often consumed by individuals seeking to improve energy levels and reduce body fat. These supplements are sold in powdered or ready-to-drink (RTD) forms and consist of a blend of ingredients such as caffeine, green tea extract, and other botanical compounds. While there is evidence that thermogenic supplements can positively affect resting energy expenditure (REE), the effect varies based on the combination of active ingredients. Additionally, there is some concern that thermogenic supplements may cause unwanted side effects on hemodynamic variables, like heart rate (HR) and blood pressure (BP). Therefore, further investigation into the efficacy and safety of commercially available products is warranted. Methods Twenty-eight individuals (14 F, 14 M; age: 23.3 ± 3.9 yrs; height: 169.4 ± 8.6 cm; body mass: 73.3 ± 13.1 kg) completed two visits in a randomized, double-blind, crossover fashion. Each visit began with baseline REE, HR, and BP assessments, which were followed by ingestion of an active RTD thermogenic beverage (RTD; OxyShred Ultra Energy) or placebo (PL). Assessments were repeated at the intervals of 35–50- and 85–100-minutes post-ingestion. In addition, subjective outcomes of energy, focus, concentration, alertness, and mood were collected five times throughout each visit. Repeated-measures analysis of variance was performed with condition and time specified as within-subjects factors and sex and resistance training (RT) status as between-subjects factors. Statistical significance was accepted at p < 0.05. Results A significant condition × time interaction was observed for REE (p < 0.001). Higher REE values were demonstrated at 35–50 min (0.08 ± 0.02 kcal/min; p = 0.001; 5.2% difference) and 85–100 min (0.08 ± 0.02 kcal/min; p = 0.001; 5.5% difference) after RTD ingestion as compared to PL. No significant condition × time interactions were observed for respiratory quotient, HR, or BP. Condition main effects indicated lower HR (3.0 ± 0.9 bpm; p = 0.003), higher SBP (3.5 ± 1.1 mm Hg; p = 0.003) and higher DBP (3.5 ± 0.9 mm Hg; p < 0.001) in RTD as compared to PL, irrespective of time. Condition × time interactions were observed for all subjective outcomes (p ≤ 0.02). Post hoc tests indicated statistically significant benefits of the RTD over PL for energy, focus, concentration, and alertness, without significant differences for mood after correction for multiple comparisons. Sex and RT status were not involved in interactions for any outcomes, except for a Sex × RT status interaction for energy, indicating higher energy ratings in non-resistance-trained vs. resistance-trained males. Conclusions These data suggest that acute ingestion of a thermogenic RTD beverage significantly increases REE, and this elevated caloric expenditure is sustained for at least 100 minutes following ingestion. Furthermore, the RTD beverage increased measures of energy, focus, concentration, and alertness as compared to placebo. While minor differences in hemodynamic variables were observed between conditions, all values stayed within normal ranges. Individuals aiming to increase energy expenditure may benefit from acute ingestion of an RTD thermogenic supplement

    Evaluation of novel beverage formulations for hydration enhancement in humans

    No full text
    This study evaluated the influence of novel beverage formulations on bioimpedance- and urine-based hydration markers. Thirty young healthy adults (n=16 females, n=14 males; age: 23.2±3.7 years; BMI: 24.3±3.3 kg/m2) participated in a randomized, double-blind, placebo-controlled, crossover study. Participants completed three conditions with baseline bioimpedance, urine, and body mass assessments, followed by ingestion of one liter of a test beverage over a 30-minute period. The three beverages were: active hydration formulation in still (AFstill) or sparkling (AFspark) water and a still water control. The active formulations were identical in concentrations of alpha-cyclodextrin and complexing agents. Following beverage ingestion, bioimpedance assessments were performed every 15 minutes for two hours, followed by final urinary and body mass assessments. The primary bioimpedance outcomes were phase angle at 50 kHz, resistance of the extra-cellular compartment (R0), and resistance of the intracellular compartment (Ri). Data were analyzed using linear mixed effects models, Friedman tests, and Wilcoxon tests. Statistically significant changes in phase angle values were observed at 30 (p=0.004) and 45 minutes (p=0.024) following the initiation of beverage ingestion in the AFstill condition as compared to the reference model (i.e., control condition at baseline). Although differences between conditions were not statistically significant at later time points, the data were consistent with AFstill having greater elevations in phase angle throughout the monitoring period. At the 30-minute time point only, statistically significant differences in R0 for AFspark (p<0.001) and in Ri for AFstill (p=0.008) were observed. When averaged across post-ingestion time points, there was a trend (p=0.08) for Ri differences between conditions. The net fluid balance was greater than zero, indicating retention of ingested fluid, for AFstill (p=0.02) and control (p=0.03), with a trend for AFspark (p=0.06). In conclusion, an active formulation containing alpha-cyclodextrin in still water demonstrated potential benefits for enhancing hydration markers in humans
    corecore